UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

Current Work

Hilda de Jong

Project Title: The long-term Benefits and Adverse effects of Beta-interferon for Multiple Sclerosis, New indications for old drugs: Do statins, angiotensin converting enzyme inhibitors or proton pump inhibitors impact long-term disease progression in MS?


Mohammad Ehsanul Karim (Ehsan)

Project Title: Long-term Benefits and Adverse Effects of Beta-interferon for Multiple Sclerosis


Elaine Kingwell

Project Titles: Survival and Cause of Death in the British Columbian Multiple Sclerosis Population and Malignancy and multiple sclerosis: incidence and impact of beta-interferon treatment


Kaarina Kowalec

Project Title: Genotype specific approaches to preventing interferon beta-induced liver injury in multiple sclerosis


Kyla McKay

Project Title: Mood disorders and multiple sclerosis: a focus on disease-modifying therapies


Neda Rezaz-Rahmati

Project Title: Children of Multiple Sclerosis: impact of chronic disease in parents on early childhood development

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia